Ariad wins key patent for leukemia drug
Ariad wins key patent for leukemia drug
Ariad Pharmaceuticals Inc. is set to disclose today that it has won a key patent on its drug to treat a form of leukemia, giving the Cambridge biotechnology company patent protection through 2026 on what could become a major cancer-fighting therapy. Shares of Ariad have more than doubled in price over the past year, climbing sharply since the start of 2012, amid projections that ponatinib, its …
MacroSolve Files Patent Infringement Suits Against Yelp and Newegg
TULSA, OK– – MacroSolve, Inc., , a leading provider of mobile technologies, apps and solutions for business, today announced its latest patent infringement suits filed against Yelp, Inc., the operator …
Natural Alternatives International, Inc. Files Patent Infringement Claim Against DNP International Co., Inc.
SAN MARCOS, Calif., Feb. 14, 2012 /PRNewswire/ — Natural Alternatives International, Inc. (“NAI”) (NASDAQ: NAII – News), a leading formulator, manufacturer and marketer of customized nutritional supplements, …
Microbix’ LumiSort Patent Withstands Competitive Challenge
Microbix’ LumiSort Patent Withstands Competitive Challenge
Get social with this patent (we think)
Get social with this patent (we think) The Salt Lake Tribune Published Feb 14, 2012 01:57PM MDT Using Internet content as a means to establish live social networks by linking internet users to each other who are simultaneously engaged in the same and/or similar content, patent No. 8,117,281, invented by Jack Robinson of Vacaville, Calif., Peter Muller of Woodside, Calif., Timothy Noke of Santa …
Pathfinder Announces First European Patent Allowance for Pathfinder Cells
CAMBRIDGE, Mass. — Pathfinder Cell Therapy, Inc. (“Pathfinder,” or “the Company”) (OTCQB:PFND.PK – News), a biotechnology company focused on the treatment of diseases characterized by organ-specific …
New Patent Promises to Accelerate Cancer Trials
TAMPA, Fla., Feb. 14, 2012 /PRNewswire/ — A new patent has been issued to Moffitt Cancer Center for a computerized system that efficiently selects the right patient for the right clinical trial. The newly …
ParkerVision Announces Markman Hearing in Patent Infringement Lawsuit Against Qualcomm
JACKSONVILLE, Fla., Feb. 15, 2012 /PRNewswire/ — ParkerVision, Inc. (NASDAQ: PRKR – News), a developer and marketer of semiconductor technology solutions for wireless applications, announced today that U.S. …